Please use this identifier to cite or link to this item:
Title: Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia
Authors: Monteiro, Pedro 
Duarte, Ana I. 
Gonçalves, Lino M. 
Moreno, António 
Providência, Luís A. 
Keywords: Ischemia; Mitochondrion; Trimetazidine; Perfusion; Glucose
Issue Date: 2004
Citation: European Journal of Pharmacology. 503:1-3 (2004) 123-128
Abstract: Trimetazidine is an anti-ischemic drug whose cytoprotective mechanisms are not yet fully understood (but until now mainly related to the trimetazidine-induced "metabolic shift" from lipid [beta]-oxidation to glucose aerobic oxidation). We studied the effect of trimetazidine on the mitochondrial function of ischemic Wistar rat hearts perfused with glucose, using a model of ex-vivo perfusion (Langendorff system). We measured the electrical potential of the mitochondrial membrane, O2 consumption by the respiratory chain, energy charges generated and the enzyme activities of the respiratory chain complexes. In this model, trimetazidine had a preferential action on the oxidative system (mainly on complex I), increasing its enzyme activity and decreasing O2 consumption after phosphorylation; this could decrease oxygen free radical production and increase mitochondrial integrity, thus allowing the maintenance of the electrical potential. These results allow us to better understand the cytoprotective effects of trimetazidine in coronary artery disease.
DOI: 10.1016/j.ejphar.2004.09.003
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
file47ceeccccce94a8682a8bdc7719d21b1.pdf299.98 kBAdobe PDFView/Open
Show full item record


checked on Oct 2, 2021

Page view(s) 50

checked on Oct 13, 2021


checked on Oct 13, 2021

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.